• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
RNA modifications and cancer.RNA 修饰与癌症。
RNA Biol. 2020 Nov;17(11):1560-1575. doi: 10.1080/15476286.2020.1722449. Epub 2020 Feb 7.
2
N-methyladenosine methylome in messenger RNA and non-coding RNA.mRNA 和非编码 RNA 中的 N6-甲基腺苷甲基组。
Curr Opin Chem Biol. 2018 Aug;45:179-186. doi: 10.1016/j.cbpa.2018.06.017. Epub 2018 Jul 9.
3
Transcriptome-wide profiling of multiple RNA modifications simultaneously at single-base resolution.在单碱基分辨率上同时进行多个 RNA 修饰的转录组范围分析。
Proc Natl Acad Sci U S A. 2019 Apr 2;116(14):6784-6789. doi: 10.1073/pnas.1817334116. Epub 2019 Mar 14.
4
Targeted mA reader proteins to study the epitranscriptome.靶向mA阅读器蛋白以研究表观转录组。
Methods Enzymol. 2019;621:1-16. doi: 10.1016/bs.mie.2019.02.035. Epub 2019 Mar 13.
5
Deciphering the Epitranscriptomic Signatures in Cell Fate Determination and Development.解析细胞命运决定和发育中的表观转录组特征。
Stem Cell Rev Rep. 2019 Aug;15(4):474-496. doi: 10.1007/s12015-019-09894-3.
6
Role of RNA modifications in cancer metastasis.RNA 修饰在癌症转移中的作用。
Curr Opin Genet Dev. 2024 Aug;87:102232. doi: 10.1016/j.gde.2024.102232. Epub 2024 Jul 22.
7
The emerging biology of RNA post-transcriptional modifications.RNA转录后修饰的新兴生物学
RNA Biol. 2017 Feb;14(2):156-163. doi: 10.1080/15476286.2016.1267096. Epub 2016 Dec 12.
8
Unraveling the RNA modification code with mass spectrometry.利用质谱技术揭示 RNA 修饰密码。
Mol Omics. 2020 Aug 1;16(4):305-315. doi: 10.1039/c8mo00247a. Epub 2020 Apr 14.
9
The role of mA, mC and Ψ RNA modifications in cancer: Novel therapeutic opportunities.mA、mC 和 Ψ RNA 修饰在癌症中的作用:新的治疗机会。
Mol Cancer. 2021 Jan 18;20(1):18. doi: 10.1186/s12943-020-01263-w.
10
A Census and Categorization Method of Epitranscriptomic Marks.转录组修饰的普查与分类方法。
Int J Mol Sci. 2020 Jun 30;21(13):4684. doi: 10.3390/ijms21134684.

引用本文的文献

1
Targeting epigenetic modifications as an emerging immunotherapeutic strategy for cancers.将表观遗传修饰作为一种新兴的癌症免疫治疗策略。
Immunol Res. 2025 Aug 19;73(1):121. doi: 10.1007/s12026-025-09678-7.
2
Comprehensive bioinformatics analysis of EXOSC family genes in head and neck squamous cell carcinoma.头颈部鳞状细胞癌中EXOSC家族基因的综合生物信息学分析
Sci Rep. 2025 Aug 19;15(1):30361. doi: 10.1038/s41598-025-15758-3.
3
The role of m5C, m1A and m7G modifications in tumors of urinary system.m5C、m1A和m7G修饰在泌尿系统肿瘤中的作用。
Front Cell Dev Biol. 2025 Jul 30;13:1549588. doi: 10.3389/fcell.2025.1549588. eCollection 2025.
4
Ribosome Biogenesis and Function in Cancer: From Mechanisms to Therapy.核糖体生物合成与在癌症中的功能:从机制到治疗
Cancers (Basel). 2025 Jul 31;17(15):2534. doi: 10.3390/cancers17152534.
5
Yin Yang 1 protein-activated N-acetyltransferase 10 drives cell malignant progression of osteosarcoma through ac4C acetylation of integrin β3.阴阳1蛋白激活的N-乙酰转移酶10通过整合素β3的ac4C乙酰化驱动骨肉瘤细胞的恶性进展。
J Bone Oncol. 2025 Jul 12;53:100701. doi: 10.1016/j.jbo.2025.100701. eCollection 2025 Aug.
6
The Biological Role of LRPPRC in Human Cancers.LRPPRC在人类癌症中的生物学作用
Cancer Control. 2025 Jan-Dec;32:10732748251353077. doi: 10.1177/10732748251353077. Epub 2025 Jun 30.
7
Pan-cancer analysis identifies DBF4B as an immunologic and prognostic biomarker.泛癌分析确定DBF4B为一种免疫和预后生物标志物。
J Cancer. 2025 Jun 12;16(8):2626-2648. doi: 10.7150/jca.109134. eCollection 2025.
8
TRMT6-mediated tRNA mA modification acts as a translational checkpoint of histone synthesis and facilitates colorectal cancer progression.TRMT6介导的tRNA mA修饰作为组蛋白合成的翻译检查点并促进结直肠癌进展。
Nat Cancer. 2025 Jun 3. doi: 10.1038/s43018-025-00977-4.
9
ESR1 overexpression is a biomarker of relapse and worse prognosis in stage I endometrioid endometrial carcinoma.ESR1过表达是I期子宫内膜样子宫内膜癌复发和预后较差的生物标志物。
Braz J Med Biol Res. 2025 May 9;58:e14494. doi: 10.1590/1414-431X2025e14494. eCollection 2025.
10
A coagulation-related long non-coding RNA signature to predict prognosis and immune features of breast cancer.一种用于预测乳腺癌预后和免疫特征的凝血相关长链非编码RNA特征
Discov Oncol. 2025 May 3;16(1):662. doi: 10.1007/s12672-025-02316-6.

本文引用的文献

1
Reading, writing and erasing mRNA methylation.阅读、书写和擦除 mRNA 甲基化。
Nat Rev Mol Cell Biol. 2019 Oct;20(10):608-624. doi: 10.1038/s41580-019-0168-5. Epub 2019 Sep 13.
2
m1A Regulated Genes Modulate PI3K/AKT/mTOR and ErbB Pathways in Gastrointestinal Cancer.m1A调控基因在胃肠道癌中调节PI3K/AKT/mTOR和ErbB信号通路。
Transl Oncol. 2019 Oct;12(10):1323-1333. doi: 10.1016/j.tranon.2019.06.007. Epub 2019 Jul 25.
3
Interplay Between -Methyladenosine (mA) and Non-coding RNAs in Cell Development and Cancer.N6-甲基腺苷(m6A)与非编码RNA在细胞发育和癌症中的相互作用
Front Cell Dev Biol. 2019 Jun 28;7:116. doi: 10.3389/fcell.2019.00116. eCollection 2019.
4
Sensitive and quantitative probing of pseudouridine modification in mRNA and long noncoding RNA.灵敏且定量探测 mRNA 和长非编码 RNA 中的假尿嘧啶修饰。
RNA. 2019 Sep;25(9):1218-1225. doi: 10.1261/rna.072124.119. Epub 2019 Jun 21.
5
RNA modifications regulating cell fate in cancer.RNA 修饰调控癌症中的细胞命运。
Nat Cell Biol. 2019 May;21(5):552-559. doi: 10.1038/s41556-019-0319-0. Epub 2019 May 2.
6
The chemical diversity of RNA modifications.RNA 修饰的化学多样性。
Biochem J. 2019 Apr 26;476(8):1227-1245. doi: 10.1042/BCJ20180445.
7
Regulation of Gene Expression by N-methyladenosine in Cancer.N6-甲基腺苷在癌症中对基因表达的调控。
Trends Cell Biol. 2019 Jun;29(6):487-499. doi: 10.1016/j.tcb.2019.02.008. Epub 2019 Mar 30.
8
[Research progress on synthetic scaffold in metabolic engineering - a review].[代谢工程中合成支架的研究进展——综述]
Sheng Wu Gong Cheng Xue Bao. 2019 Mar 25;35(3):363-374. doi: 10.13345/j.cjb.180298.
9
Epitranscriptomic Signatures in lncRNAs and Their Possible Roles in Cancer.lncRNAs 中的表观转录组特征及其在癌症中的可能作用。
Genes (Basel). 2019 Jan 16;10(1):52. doi: 10.3390/genes10010052.
10
Roles of Elongator Dependent tRNA Modification Pathways in Neurodegeneration and Cancer.延伸因子依赖性tRNA修饰途径在神经退行性疾病和癌症中的作用
Genes (Basel). 2018 Dec 28;10(1):19. doi: 10.3390/genes10010019.

RNA 修饰与癌症。

RNA modifications and cancer.

机构信息

Department of Chemistry and the RNA Institute, College of Arts and Science, University at Albany, State University of New York , Albany, NY, USA.

Institute of Biosciences and Technology, Texas A&M University , Houston, TX, USA.

出版信息

RNA Biol. 2020 Nov;17(11):1560-1575. doi: 10.1080/15476286.2020.1722449. Epub 2020 Feb 7.

DOI:10.1080/15476286.2020.1722449
PMID:31994439
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7567502/
Abstract

RNA plays essential roles in not only translating nucleic acids into proteins, but also in gene regulation, environmental interactions and many human diseases. Nature uses over 150 chemical modifications to decorate RNA and diversify its functions. With the fast-growing RNA research in the burgeoning field of 'epitranscriptome', a term describes post-transcriptional RNA modifications that can dynamically change the transcriptome, it becomes clear that these modifications participate in modulating gene expression and controlling the cell fate, thereby igniting the new interests in RNA-based drug discovery. The dynamics of these RNA chemical modifications is orchestrated by coordinated actions of an array of writer, reader and eraser proteins. Deregulated expression of these RNA modifying proteins can lead to many human diseases including cancer. In this review, we highlight several critical modifications, namely mA, mA, mC, inosine and pseudouridine, in both coding and non-coding RNAs. In parallel, we present a few other cancer-related tRNA and rRNA modifications. We further discuss their roles in cancer promotion or tumour suppression. Understanding the molecular mechanisms underlying the biogenesis and turnover of these RNA modifications will be of great significance in the design and development of novel anticancer drugs.

摘要

RNA 在将核酸翻译成蛋白质方面发挥着重要作用,同时也在基因调控、环境相互作用和许多人类疾病中发挥着重要作用。自然界利用超过 150 种化学修饰来修饰 RNA,使其功能多样化。随着“转录后组学”这一新兴领域中 RNA 研究的快速发展,人们清楚地认识到这些修饰可以动态改变转录组,参与调节基因表达和控制细胞命运,从而激发了基于 RNA 的新药发现的新兴趣。这些 RNA 化学修饰的动态由一系列 Writer、Reader 和 Eraser 蛋白的协调作用来调控。这些 RNA 修饰蛋白的表达失调可导致许多人类疾病,包括癌症。在这篇综述中,我们重点介绍了编码和非编码 RNA 中的几种关键修饰,即 mA、m 6 A、m 5 C、肌苷和假尿嘧啶。同时,我们还介绍了其他几种与癌症相关的 tRNA 和 rRNA 修饰。我们进一步讨论了它们在促进癌症或抑制肿瘤方面的作用。了解这些 RNA 修饰的生物发生和周转的分子机制对于设计和开发新型抗癌药物具有重要意义。